LYRA THERAPEUTICS INC's ticker is LYRA and the CUSIP is 55234L105.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $195 | -33.2% | 49,800 | -29.9% | 0.00% | – |
| Q2 2023 | $292 | +204.2% | 71,000 | +48.4% | 0.00% | – |
| Q1 2023 | $96 | -17.9% | 47,851 | +28.6% | 0.00% | – |
| Q4 2022 | $117 | -99.9% | 37,200 | -7.0% | 0.00% | – |
| Q3 2022 | $200,000 | -13.8% | 40,000 | -2.4% | 0.00% | – |
| Q2 2022 | $232,000 | +231.4% | 41,000 | +134.3% | 0.00% | – |
| Q1 2022 | $70,000 | -69.2% | 17,500 | -66.3% | 0.00% | – |
| Q4 2021 | $227,000 | – | 52,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|